Managing Device‐Aided Treatments in Parkinson's Disease in Times of COVID‐19

We read with interest the viewpoint review from Fasano and colleagues1 on the management of advanced therapies in patients with Parkinson's disease (PD) during the COVID-19 pandemic. We agree with the authors that this crisis may be turned into an opportunity. Our national health care systems should actively support clinicians in the remote management of chronic neurological patients, including those with advanced PD. Similar to other countries,...